We are live on
!
Find out more
Vise Technologies Portfolio holdings
AUM
$8.83B
Turnover
36.58%
1-Year Est. Return
27.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.82%
1 Year Est. Return
+27.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
-$12M
(-0.24%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
1,461
New
–
Increased
–
Reduced
3
Closed
14
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.2
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.19M |
| 2 |
Frontier Communications
FYBR
|
+$1.31M |
| 3 |
Amcor
AMCR
|
+$1.21M |
| 4 |
Exact Sciences
EXAS
|
+$1.19M |
| 5 |
Piper Sandler
PIPR
|
+$932K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.26% |
| 2 | Technology | 15.38% |
| 3 | Financials | 8.06% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Communication Services | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Phillips 66
PSX
$117B
| $2.62M | 0.05% |
20,327
| – | – |
2022 Q4
13 quarters
|
|
302
Sherwin-Williams
SHW
$81.4B
| $2.59M | 0.05% |
7,980
| – | – |
2021 Q4
17 quarters
|
|
303
Sanofi
SNY
$97.3B
| $2.58M | 0.05% |
53,313
| – | – |
2022 Q1
16 quarters
|
|
304
Moody's
MCO
$84B
| $2.55M | 0.05% |
4,999
| – | – |
2024 Q2
7 quarters
|
|
305
Vanguard California Tax-Exempt Bond ETF
VTEC
$3.66B
| $2.54M | 0.05% |
25,380
| – | – |
2025 Q4
1 quarter
|
|
306
Sprott Physical Gold
PHYS
$14.9B
| $2.54M | 0.05% |
76,798
| – | – |
2025 Q2
3 quarters
|
|
307
Boeing
BA
$150B
| $2.52M | 0.05% |
11,627
| – | – |
2024 Q3
6 quarters
|
|
308
Simplify Managed Futures Strategy ETF
CTA
$1.38B
| $2.48M | 0.05% |
91,075
| – | – |
2025 Q3
2 quarters
|
|
309
Southern Copper
SCCO
$169B
| $2.48M | 0.05% |
17,650
-150
| -0.8% | -$27.1K |
2023 Q1
12 quarters
|
|
310
CRH
CRH
$55.6B
| $2.46M | 0.05% |
19,718
| – | – |
2022 Q2
15 quarters
|
|
311
Dimensional US Sustainability Core 1 ETF
DFSU
$2.36B
| $2.46M | 0.05% |
56,589
| – | – |
2025 Q3
2 quarters
|
|
312
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.7B
| $2.44M | 0.05% |
51,765
| – | – |
2022 Q2
15 quarters
|
|
313
iShares Russell 2000 ETF
IWM
$76.2B
| $2.43M | 0.05% |
9,885
| – | – |
2024 Q3
6 quarters
|
|
314
Vanguard Information Technology ETF
VGT
$146B
| $2.43M | 0.05% |
25,808
| – | – |
2024 Q3
6 quarters
|
|
315
Cintas
CTAS
$84.9B
| $2.42M | 0.05% |
12,875
| – | – |
2024 Q1
8 quarters
|
|
316
Cigna
CI
$79.9B
| $2.41M | 0.05% |
8,774
| – | – |
2022 Q2
15 quarters
|
|
317
AB InBev
BUD
$163B
| $2.41M | 0.05% |
37,705
| – | – |
2022 Q2
15 quarters
|
|
318
Constellation Energy
CEG
$96.1B
| $2.4M | 0.05% |
6,805
| – | – |
2024 Q3
6 quarters
|
|
319
O'Reilly Automotive
ORLY
$72.2B
| $2.4M | 0.05% |
26,272
| – | – |
2024 Q2
7 quarters
|
|
320
Vertex Pharmaceuticals
VRTX
$127B
| $2.38M | 0.05% |
5,259
| – | – |
2024 Q3
6 quarters
|
|
321
iShares MSCI Emerging Markets ex China ETF
EMXC
$24.1B
| $2.38M | 0.05% |
32,791
| – | – |
2025 Q4
1 quarter
|
|
322
Leidos
LDOS
$15.7B
| $2.38M | 0.05% |
13,184
| – | – |
2024 Q2
7 quarters
|
|
323
Builders FirstSource
BLDR
$5.88B
| $2.38M | 0.05% |
23,107
| – | – |
2024 Q3
6 quarters
|
|
324
Freeport-McMoran
FCX
$99.9B
| $2.36M | 0.05% |
46,540
| – | – |
2022 Q4
13 quarters
|
|
325
Fidelity National Information Services
FIS
$18.6B
| $2.36M | 0.05% |
35,513
| – | – |
2024 Q3
6 quarters
|
|
Similar funds
GRQ
Vise Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Vise Technologies held 1,461 positions worth $5.09B, down 0.24% from $5.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0.96%. Vise Technologies opened no new positions and exited 14, leaving the 1,461-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Vise Technologies's biggest Q1 2026 reduction was StoneX, cutting an estimated $101K.
- Vise Technologies fully exited AstraZeneca in Q1 2026, selling an estimated $5.19M.
- Vise Technologies's ten largest holdings make up 27% of its $5.09B portfolio in Q1 2026.
- Vise Technologies opened 0 new positions and closed 14 in Q1 2026.
- Vise Technologies's portfolio value fell 0.24% quarter-over-quarter to $5.09B.
Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.